The effect of zoledronic acid (Zol) dose and infusion rate on pharmacokinetics (PK), pharmacodynamics (PD), and renal function in patients (pts) with multiple myeloma (MM) or prostate cancer (PC) and bone metastases Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Major, Pierre
  • Berenson, J
  • Swift, R
  • Vescio, R
  • Ravera, C
  • Bilic, S
  • Gauron, S
  • Denouel, J
  • Schran, H

publication date

  • June 2005